Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans

Efforts to selectively target and disrupt established tumor vasculature have largely failed to date. We hypothesized that a vaccinia virus engineered to target cells with activation of the ras/MAPK signaling pathway (JX-594) could specifically infect and express transgenes (hGM-CSF, β-galactosidase)...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer research (Chicago, Ill.) Ill.), 2013-02, Vol.73 (4), p.1265-1275
Hauptverfasser: BREITBACH, Caroline J, ARULANANDAM, Rozanne, HEO, Jeong, CHO, Mong, CHEN, Hannah, ANGARITA, Fernando A, ADDISON, Christina, ANDREA MCCART, J, BELL, John C, KIRN, David H, DE SILVA, Naomi, THORNE, Steve H, PATT, Richard, DANESHMAND, Manijeh, MOON, Anne, ILKOW, Carolina, BURKE, James, HWANG, Tae-Ho
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!